{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T08:04:34Z","timestamp":1780560274079,"version":"3.54.1"},"reference-count":95,"publisher":"Hindawi Limited","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1523,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1111\/j.1529-8019.2011.01430.x","type":"journal-article","created":{"date-parts":[[2011,9,12]],"date-time":"2011-09-12T19:14:09Z","timestamp":1315854849000},"page":"432-442","source":"Crossref","is-referenced-by-count":78,"title":["Treatment of chemotherapy-induced alopecia"],"prefix":"10.1155","volume":"24","author":[{"given":"CAROLINE E.","family":"YEAGER","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ELISE A.","family":"OLSEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2011,9,12]]},"reference":[{"issue":"2","key":"10.1111\/j.1529-8019.2011.01430.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0277-5379(83)90418-2","article-title":"On the receiving end - patient perception of the side-effects of cancer chemotherapy","volume":"19","author":"Coates","year":"1983","journal-title":"Eur J Cancer Clin Oncol"},{"issue":"6","key":"10.1111\/j.1529-8019.2011.01430.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/00002820-198412000-00006","article-title":"Alopecia: effect on cancer patients' body image","volume":"7","author":"Baxley","year":"1984","journal-title":"Cancer Nurs"},{"issue":"10","key":"10.1111\/j.1529-8019.2011.01430.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/0277-5379(90)90046-V","article-title":"Effect of peri-operative chemotherapy on the quality of life of patients with early breast cancer","volume":"26","author":"Kiebert","year":"1990","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1111\/j.1529-8019.2011.01430.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1364-9825(97)80184-8","article-title":"Survey of the incidence and severity of side-effects reported by patients receiving six cycles of FEC chemotherapy","volume":"1","author":"Sitzia","year":"1997","journal-title":"J Cancer Nurs"},{"issue":"1","key":"10.1111\/j.1529-8019.2011.01430.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1046\/j.1523-5394.1998.1998006013.x","article-title":"Side effects of cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) chemotherapy for breast cancer","volume":"6","author":"Sitzia","year":"1998","journal-title":"Cancer Pract"},{"issue":"2","key":"10.1111\/j.1529-8019.2011.01430.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1523-5394.1999.07205.x","article-title":"Perception of chemotherapy side effects cancer versus noncancer patients","volume":"7","author":"Lindley","year":"1999","journal-title":"Cancer Pract"},{"issue":"1","key":"10.1111\/j.1529-8019.2011.01430.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/cncr.10630","article-title":"Changing patient perceptions of the side effects of cancer chemotherapy","volume":"95","author":"Carelle","year":"2002","journal-title":"Cancer"},{"issue":"11","key":"10.1111\/j.1529-8019.2011.01430.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1093\/annonc\/mdi370","article-title":"Patients' preferences for adjuvant chemotherapy in early breast cancer: what makes AC and CMF worthwhile now?","volume":"16","author":"Duric","year":"2005","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1111\/j.1529-8019.2011.01430.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/pon.1245","article-title":"Chemotherapy-induced alopecia and effects on quality of life among women with breast cancer: a literature review","volume":"17","author":"Lemieux","year":"2008","journal-title":"Psychooncology"},{"issue":"4","key":"10.1111\/j.1529-8019.2011.01430.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/00002820-199408000-00006","article-title":"Social and cultural dimensions of hair loss in women treated for breast cancer","volume":"17","author":"Freedman","year":"1994","journal-title":"Cancer Nurs"},{"issue":"2","key":"10.1111\/j.1529-8019.2011.01430.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1471-6712.1992.tb00128.x","article-title":"Knowledge, expectations, and experiences of patients receiving chemotherapy for breast cancer","volume":"6","author":"Tierney","year":"1992","journal-title":"Scand J Caring Sci"},{"issue":"1","key":"10.1111\/j.1529-8019.2011.01430.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/00002820-200601000-00006","article-title":"Postmenopausal women with breast cancer: their experiences of the chemotherapy treatment period","volume":"29","author":"Browall","year":"2006","journal-title":"Cancer Nurs"},{"issue":"6","key":"10.1111\/j.1529-8019.2011.01430.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/(SICI)1099-1611(199911\/12)8:6<467::AID-PON400>3.0.CO;2-P","article-title":"Work problems after breast cancer: an exploratoy qualitative study","volume":"8","author":"Maunsell","year":"1999","journal-title":"Psychooncology"},{"issue":"1","key":"10.1111\/j.1529-8019.2011.01430.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1188\/02.ONF.113-119","article-title":"Living in it, living with it, and moving on: dimensions of meaning during chemotherapy","volume":"29","author":"Richer","year":"2002","journal-title":"Oncol Nurs Forum"},{"issue":"3","key":"10.1111\/j.1529-8019.2011.01430.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0738-3991(03)00040-5","article-title":"Cancer and stigma: experience of patients with chemotherapy-induced alopecia","volume":"52","author":"Rosman","year":"2004","journal-title":"Patient Educ Couns"},{"issue":"2","key":"10.1111\/j.1529-8019.2011.01430.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1023\/B:BREA.0000032983.87966.4e","article-title":"Health-related quality of life in axillary node-negative, estrogen receptor-negative breast cancer patients undergoing AC versus CMF chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel Project B-23","volume":"86","author":"Land","year":"2004","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1111\/j.1529-8019.2011.01430.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.lungcan.2010.07.004","article-title":"Perception of alopecia by patients requiring chemotherapy for non-small-cell lung cancer: a willingness to pay study","volume":"72","author":"Bernard","year":"2011","journal-title":"Lung Cancer"},{"issue":"6","key":"10.1111\/j.1529-8019.2011.01430.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/pon.1272","article-title":"Have men been overlooked? A comparison of young men and women's experiences of chemotherapy-induced alopecia","volume":"17","author":"Hilton","year":"2008","journal-title":"Psychooncology"},{"key":"10.1111\/j.1529-8019.2011.01430.x-BIB19|cit19","first-page":"381","volume-title":"The MASCC textbook of cancer supportive care and survivorship","author":"Olsen","year":"2011"},{"key":"10.1111\/j.1529-8019.2011.01430.x-BIB20|cit20","unstructured":"American Cancer Society Hair loss http:\/\/www.cancer.org\/Treatment\/TreatmentsandSideEffects\/PhysicalSideEffects\/DealingwithSymptomsatHome\/caring-for-the-patient-with-cancer-at-home-hair-loss"},{"issue":"1","key":"10.1111\/j.1529-8019.2011.01430.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.sder.2008.12.001","article-title":"Chemotherapy-induced alopecia","volume":"28","author":"Trueb","year":"2009","journal-title":"Semin Cutan Med Surg"},{"key":"10.1111\/j.1529-8019.2011.01430.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/annonc\/mdi088","article-title":"Prevention of chemotherapy-induced hair loss by scalp-cooling","volume":"16","author":"Grevelman","year":"2005","journal-title":"Ann Oncol"},{"issue":"8031","key":"10.1111\/j.1529-8019.2011.01430.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0140-6736(77)92877-X","article-title":"Doxorubicin-induced hair loss and possible modification by scalp cooling","volume":"2","author":"Edelstyn","year":"1977","journal-title":"Lancet"},{"issue":"1","key":"10.1111\/j.1529-8019.2011.01430.x-BIB24|cit24","first-page":"19","article-title":"The effect of using Chemocap on occurrence of chemotherapy-induced alopecia","volume":"10","author":"Kennedy","year":"1983","journal-title":"Oncol Nurs Forum"},{"issue":"1","key":"10.1111\/j.1529-8019.2011.01430.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/1097-0142(19840701)54:1<34::AID-CNCR2820540109>3.0.CO;2-W","article-title":"The use of scalp hypothermia in the prevention of doxorubicin-induced hair loss","volume":"54","author":"Satterwhite","year":"1984","journal-title":"Cancer"},{"issue":"6","key":"10.1111\/j.1529-8019.2011.01430.x-BIB26|cit26","first-page":"49","article-title":"The effectiveness of scalp hypothermia in preventing cyclophosphamide-induced alopecia","volume":"14","author":"Parker","year":"1987","journal-title":"Oncol Nurs Forum"},{"issue":"3","key":"10.1111\/j.1529-8019.2011.01430.x-BIB27|cit27","first-page":"170","article-title":"Scalp hypothermia in the prevention of doxorubicin-induced hair loss","volume":"11","author":"Giaccone","year":"1988","journal-title":"Cancer Nurs"},{"key":"10.1111\/j.1529-8019.2011.01430.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/BF01262571","article-title":"Scalp cooling in the prevention of alopecia in patients receiving depilating chemotherapy","volume":"5","author":"Ron","year":"1997","journal-title":"Support Care Cancer"},{"issue":"2","key":"10.1111\/j.1529-8019.2011.01430.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1046\/j.1365-2354.2003.00382.x","article-title":"The effectiveness of scalp cooling in preventing alopecia for patients receiving epirubicin and docetaxel","volume":"12","author":"Macduff","year":"2003","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"34","key":"10.1111\/j.1529-8019.2011.01430.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"5618","DOI":"10.1200\/JCO.2007.15.9053","article-title":"Nonpharmacologic strategies for managing common chemotherapy adverse effects: a systematic review","volume":"26","author":"Lofti-Jam","year":"2008","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1111\/j.1529-8019.2011.01430.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1054\/ejon.2000.0094","article-title":"Evaluating the efficacy of scalp cooling using the Penguin cold cap system to reduce alopecia in patients undergoing chemotherapy for breast cancer","volume":"4","author":"Peck","year":"2000","journal-title":"Eur J Oncol Nurs"},{"issue":"6","key":"10.1111\/j.1529-8019.2011.01430.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00520-003-0451-y","article-title":"Scalp hypothermia to prevent chemotherapy-induced alopecia is effective and safe: a pilot study of a new digitalized scalp-cooling system used in 74 patients","volume":"11","author":"Ridderheim","year":"2003","journal-title":"Support Care Cancer"},{"issue":"2","key":"10.1111\/j.1529-8019.2011.01430.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejon.2003.10.006","article-title":"A multicentre study to determine the efficacy and patient acceptability of the Paxman scalp cooler to prevent hair loss in patients receiving chemotherapy","volume":"8","author":"Massey","year":"2004","journal-title":"Eur J Oncol Nurs"},{"issue":"8","key":"10.1111\/j.1529-8019.2011.01430.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1088\/0967-3334\/28\/8\/006","article-title":"The relationship between local scalp temperature and cutaneous perfusion during scalp cooling","volume":"28","author":"Janssen","year":"2007","journal-title":"Physiol Meas"},{"issue":"3-4","key":"10.1111\/j.1529-8019.2011.01430.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11626-007-9074-9","article-title":"Effects of temperature and doxorubicin exposure on keratinocyte damage in vitro","volume":"44","author":"Janssen","year":"2008","journal-title":"In Vitro Cell Dev Biol Anim"},{"issue":"6330","key":"10.1111\/j.1529-8019.2011.01430.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1136\/bmj.284.6330.1674","article-title":"Prevention of doxorubicin-induced alopecia by scalp hypothermia: relation to degree of cooling","volume":"284","author":"Gregory","year":"1982","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1111\/j.1529-8019.2011.01430.x-BIB37|cit37","unstructured":"Weiss S Sub-zero therapy lets a chemo patient keep her hair The Washington Post. 2011 E1 E5"},{"key":"10.1111\/j.1529-8019.2011.01430.x-BIB38|cit38","first-page":"507","article-title":"Letter: misuse of scalp hypothermia","volume":"65","author":"Witman","year":"1981","journal-title":"Cancer Treat Rep"},{"key":"10.1111\/j.1529-8019.2011.01430.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0140-6736(00)04293-8","article-title":"Letter: scalp cooling therapy and cytotoxic treatment","volume":"357","author":"Forsberg","year":"2001","journal-title":"Lancet"},{"key":"10.1111\/j.1529-8019.2011.01430.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0959-8049(96)00374-7","article-title":"Effectiveness of cold cap in the prevention of docetaxel-induced alopecia","volume":"33","author":"Lemenager","year":"1997","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1111\/j.1529-8019.2011.01430.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s10549-009-0342-0","article-title":"Incidence of scalp metastases in breast cancer: a retrospective cohort study in women who were offered scalp cooling","volume":"118","author":"Lemieux","year":"2009","journal-title":"Breast Cancer Res Treat"},{"issue":"33","key":"10.1111\/j.1529-8019.2011.01430.x-BIB42|cit42","first-page":"A2134","article-title":"Allow scalp cooling during adjuvant chemotherapy in patients with breast cancer; scalp metastases rarely occur","volume":"154","author":"van de Sande","year":"2010","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"5522","key":"10.1111\/j.1529-8019.2011.01430.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/bmj.2.5522.1138","article-title":"Letter: alopecia and cytotoxic drugs","volume":"2","author":"Simister","year":"1966","journal-title":"Br Med J"},{"issue":"5522","key":"10.1111\/j.1529-8019.2011.01430.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/bmj.2.5522.1138-a","article-title":"Letter: alopecia and cytotoxic drugs","volume":"2","author":"Hennessy","year":"1966","journal-title":"Br Med J"},{"issue":"21","key":"10.1111\/j.1529-8019.2011.01430.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1056\/NEJM197805252982121","article-title":"Letter: scalp tourniquets in the prevention of chemotherapy-induced alopecia","volume":"298","author":"Pesce","year":"1978","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1111\/j.1529-8019.2011.01430.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM197809142991115","article-title":"Letter: scalp tourniquet in cancer therapy","volume":"299","author":"Soukop","year":"1978","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1111\/j.1529-8019.2011.01430.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1056\/NEJM197102112840624","article-title":"Letter: vincristine and alopecia","volume":"284","author":"Helson","year":"1971","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1111\/j.1529-8019.2011.01430.x-BIB48|cit48","first-page":"1489","article-title":"Letter: scalp tourniquet to lessen alopecia after vincristine","volume":"283","author":"O'Brien","year":"1970","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1111\/j.1529-8019.2011.01430.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/(SICI)1097-0215(19960103)65:1<97::AID-IJC17>3.0.CO;2-F","article-title":"The protective role of the immunomodulator AS101 against chemotherapy-induced alopecia studies on human and animal models","volume":"65","author":"Sredni","year":"1996","journal-title":"Int J Cancer"},{"issue":"6144","key":"10.1111\/j.1529-8019.2011.01430.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/330173a0","article-title":"A new immunomodulating compound (AS-101) with potential therapeutic application","volume":"330","author":"Sredni","year":"1987","journal-title":"Nature"},{"issue":"2","key":"10.1111\/j.1529-8019.2011.01430.x-BIB51|cit51","first-page":"129","article-title":"The use of minoxidil to attempt to prevent alopecia during chemotherapy for gynecologic malignancies","volume":"12","author":"Granai","year":"1991","journal-title":"Eur J Gynaecol Oncol"},{"issue":"8","key":"10.1111\/j.1529-8019.2011.01430.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/oxfordjournals.annonc.a058986","article-title":"Minoxidil (MX) as a prophylaxis of doxorubicin-induced alopecia","volume":"5","author":"Rodriguez","year":"1994","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1111\/j.1529-8019.2011.01430.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0190-9622(96)90500-9","article-title":"A randomized trial of minoxidil in chemotherapy-induced alopecia","volume":"35","author":"Duvic","year":"1996","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1111\/j.1529-8019.2011.01430.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00001813-199904000-00007","article-title":"A phase 1 trial of topical topitriol (calcitriol, 1, 25-dihydroxyvitamin D3) to prevent chemotherapy-induced alopecia","volume":"10","author":"Hidalgo","year":"1999","journal-title":"Anticancer Drugs"},{"issue":"4976","key":"10.1111\/j.1529-8019.2011.01430.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1126\/science.2218498","article-title":"Protection from chemotherapy-induced alopecia in a rat model","volume":"249","author":"Hussein","year":"1990","journal-title":"Science"},{"issue":"4","key":"10.1111\/j.1529-8019.2011.01430.x-BIB56|cit56","first-page":"719","article-title":"Chemotherapy-induced alopecia in mice - induction by cyclophosphamide, inhibition by cyclosporine-A, and modulation by dexamethasone","volume":"144","author":"Paus","year":"1994","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1111\/j.1529-8019.2011.01430.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/00007611-199305000-00001","article-title":"Chemotherapy-induced alopecia: new developments","volume":"86","author":"Hussein","year":"1993","journal-title":"South Med J"},{"issue":"10","key":"10.1111\/j.1529-8019.2011.01430.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1096\/fasebj.5.10.2065892","article-title":"Interleukin 1 protects from cytosine arabinoside-induced alopecia in a rat model","volume":"5","author":"Jimenez","year":"1991","journal-title":"FASEB J"},{"issue":"12","key":"10.1111\/j.1529-8019.2011.01430.x-BIB59|cit59","first-page":"3329","article-title":"Interleukin 1 protects against 1-beta-D-arabinofuranosylcytosine-induced alopecia in the newborn rat model","volume":"51","author":"Hussein","year":"1991","journal-title":"Cancer Res"},{"issue":"2","key":"10.1111\/j.1529-8019.2011.01430.x-BIB60|cit60","first-page":"413","article-title":"Protection from 1-beta-D-arabinofuranosylcytosine-induced alopecia by epidermal growth factor and fibroblast growth factor in the rat model","volume":"52","author":"Jimenez","year":"1992","journal-title":"Cancer Res"},{"issue":"1","key":"10.1111\/j.1529-8019.2011.01430.x-BIB61|cit61","first-page":"145","article-title":"Keratinocyte growth factor is an important endogenous mediator of hair follicle growth, development, and differentiation: normalization of the nu\/nu follicular differentiation defect and amelioration of chemotherapy-induced alopecia","volume":"147","author":"Danilenko","year":"1995","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1111\/j.1529-8019.2011.01430.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1096\/fasebj.8.2.8119493","article-title":"Protection against doxorubicin-induced alopecia in rats by liposome-entrapped monoclonal antibodies","volume":"8","author":"Balsari","year":"1994","journal-title":"FASEB J"},{"issue":"1-2","key":"10.1111\/j.1529-8019.2011.01430.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000211282","article-title":"Effects of cyclosporin A on hair","volume":"7","author":"Lutz","year":"1994","journal-title":"Skin Pharmacol"},{"issue":"3","key":"10.1111\/j.1529-8019.2011.01430.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1159\/000246683","article-title":"Protection against chemotherapy-induced alopecia by cyclosporine A in the newborn rat model","volume":"190","author":"Hussein","year":"1995","journal-title":"Dermatology"},{"issue":"1","key":"10.1111\/j.1529-8019.2011.01430.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0923-1811(01)00097-4","article-title":"Topical application of cyclosporin A induces rapid-remodeling of damaged anagen hair follicles produced in cyclophosphamide administered mice","volume":"27","author":"Shirai","year":"2001","journal-title":"J Dermatol Sci"},{"issue":"1","key":"10.1111\/j.1529-8019.2011.01430.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.0022-202X.2003.22120.x","article-title":"Topical estrogen accelerates hair regrowth in mice after chemotherapy-induced alopecia by favoring the dystrophic catagen response pathway to change","volume":"122","author":"Ohnemus","year":"2004","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1111\/j.1529-8019.2011.01430.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jaad.2009.06.063","article-title":"Permanent chemotherapy-induced alopecia: case report and review of the literature","volume":"63","author":"Tallon","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1111\/j.1529-8019.2011.01430.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/sj.bmt.1705817","article-title":"Six cases of permanent alopecia after various conditioning regimens commonly used in hematopoietic stem cell transplantation","volume":"40","author":"Machado","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1111\/j.1529-8019.2011.01430.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/j.1365-2133.2005.06469.x","article-title":"Permanent alopecia after busulfan chemotherapy","volume":"152","author":"Tosti","year":"2005","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1111\/j.1529-8019.2011.01430.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/sj.bmt.1703695","article-title":"Relationship between irreversible alopecia and exposure to cyclophosphamide, thiotepa and carboplatin (CTC) in high-dose chemotherapy","volume":"30","author":"de Jonge","year":"2002","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1111\/j.1529-8019.2011.01430.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1046\/j.1440-0960.2000.00405.x","article-title":"Permanent alopecia following chemotherapy and bone marrow transplantation","volume":"41","author":"Tran","year":"2000","journal-title":"Australas J Dermatol"},{"issue":"6","key":"10.1111\/j.1529-8019.2011.01430.x-BIB72|cit72","first-page":"869","article-title":"Busulfan concentration in relation to permanent alopecia in recipients of bone marrow transplants","volume":"15","author":"Ljungman","year":"1995","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1111\/j.1529-8019.2011.01430.x-BIB73|cit73","first-page":"43","article-title":"Busulphan\/cyclophosphamide conditioning for bone marrow transplantation may lead to failure of hair re-growth","volume":"7","author":"Baker","year":"1991","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1111\/j.1529-8019.2011.01430.x-BIB74|cit74","first-page":"347","article-title":"Factors affecting hair regrowth after bone marrow transplantation","volume":"12","author":"Vowels","year":"1993","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1111\/j.1529-8019.2011.01430.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1365-2133.2009.09043.x","article-title":"Irreversible and severe alopecia following docetaxel or paclitaxel cytotoxic therapy for breast cancer","volume":"160","author":"Prevezas","year":"2009","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1111\/j.1529-8019.2011.01430.x-BIB76|cit76","first-page":"13","article-title":"Permanent alopecia in women being treated for breast cancer","volume":"13","author":"Masidonski","year":"2009","journal-title":"Clin J Oncol Nurs"},{"issue":"2","key":"10.1111\/j.1529-8019.2011.01430.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1096\/fj.03-0552fje","article-title":"Hair growth induction by the tellurium immunomodulator AS101: association with delayed terminal differentiation of follicular keratinocytes and ras-dependent up-regulation of KGF expression","volume":"18","author":"Sredni","year":"2004","journal-title":"FASEB J"},{"key":"10.1111\/j.1529-8019.2011.01430.x-BIB78|cit78","unstructured":"Gleevec (package insert) 2009"},{"issue":"9","key":"10.1111\/j.1529-8019.2011.01430.x-BIB79|cit79","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1200\/JCO.1995.13.9.2342","article-title":"Bone marrow-sparing and prevention of alopecia by AS101 in non-small cell lung cancer patients treated with carboplatin and etoposide","volume":"13","author":"Sredni","year":"1995","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1111\/j.1529-8019.2011.01430.x-BIB80|cit80","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1365-4362.1995.tb00612.x","article-title":"Protection against cytosine arabinoside-induced alopecia by minoxidil in a rat animal model","volume":"34","author":"Hussein","year":"1995","journal-title":"Int J Dermatol"},{"issue":"18","key":"10.1111\/j.1529-8019.2011.01430.x-BIB176|cit81","first-page":"5123","article-title":"Protection from chemotherapy-induced alopecia by 1,25-dihydroxyvitamin D3","volume":"52","author":"Jimenez","year":"1992","journal-title":"Cancer Res"},{"issue":"2","key":"10.1111\/j.1529-8019.2011.01430.x-BIB82|cit82","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00000441-199508000-00001","article-title":"Pretreatment with 1,25(OH)2D3 protects from Cytoxan-induced alopecia without protecting the leukemic cells from Cytoxan","volume":"310","author":"Jimenez","year":"1995","journal-title":"Am J Med Sci"},{"issue":"19","key":"10.1111\/j.1529-8019.2011.01430.x-BIB83|cit83","first-page":"4438","article-title":"Topical calcitriol enhances normal hair regrowth but does not prevent chemotherapy-induced alopecia in mice","volume":"56","author":"Paus","year":"1996","journal-title":"Cancer Res"},{"issue":"6","key":"10.1111\/j.1529-8019.2011.01430.x-BIB84|cit84","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0899-9007(97)85081-2","article-title":"Vitamin D3 and chemotherapy-induced alopecia","volume":"12","author":"Jimenez","year":"1996","journal-title":"Nutrition"},{"issue":"4","key":"10.1111\/j.1529-8019.2011.01430.x-BIB85|cit85","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1046\/j.1523-1747.1998.00350.x","article-title":"Reduction of intrafollicular apoptosis in chemotherapy-induced alopecia by topical calcitriol-analogs","volume":"111","author":"Schilli","year":"1998","journal-title":"J Invest Dermatol"},{"issue":"18","key":"10.1111\/j.1529-8019.2011.01430.x-BIB181|cit86","first-page":"5002","article-title":"p53 is essential for chemotherapy-induced hair loss","volume":"60","author":"Botchkarev","year":"2000","journal-title":"Cancer Res"},{"issue":"5501","key":"10.1111\/j.1529-8019.2011.01430.x-BIB182|cit87","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1126\/science.291.5501.134","article-title":"Prevention of chemotherapy-induced alopecia in rats by CDK inhibitors","volume":"291","author":"Davis","year":"2001","journal-title":"Science"},{"issue":"5602","key":"10.1111\/j.1529-8019.2011.01430.x-BIB183|cit88","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1126\/science.298.5602.2327b","article-title":"Retraction","volume":"298","author":"Davis","year":"2002","journal-title":"Science"},{"issue":"1","key":"10.1111\/j.1529-8019.2011.01430.x-BIB184|cit89","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0014-2999(01)01489-3","article-title":"Inhibitory effect of M50054, a novel inhibitor of apoptosis, on anti-Fas-antibody-induced hepatitis and chemotherapy-induced alopecia","volume":"433","author":"Tsuda","year":"2001","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1111\/j.1529-8019.2011.01430.x-BIB185|cit90","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s12192-007-0005-1","article-title":"Prevention of chemotherapy-induced alopecia in rodent models","volume":"13","author":"Jimenez","year":"2008","journal-title":"Cell Stress Chaperones"},{"issue":"4","key":"10.1111\/j.1529-8019.2011.01430.x-BIB186|cit91","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3109\/07357909209032751","article-title":"Treatment with ImuVert\/N-acetylcysteine protects rats from cyclophosphamide\/cytarabine-induced alopecia","volume":"10","author":"Jimenez","year":"1992","journal-title":"Cancer Invest"},{"issue":"2","key":"10.1111\/j.1529-8019.2011.01430.x-BIB187|cit92","first-page":"217","article-title":"Inhibition by oral N-acetylcysteine of doxorubicin-induced clastogenicity and alopecia, and prevention of primary tumors and lung micrometastases in mice","volume":"13","author":"D'Agostini","year":"1998","journal-title":"Int J Oncol"},{"issue":"2","key":"10.1111\/j.1529-8019.2011.01430.x-BIB188|cit93","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.0022-202x.2001.01410.x","article-title":"A new strategy for modulating chemotherapy-induced alopecia, using PTH\/PTHrP receptor agonist and antagonist","volume":"117","author":"Peters","year":"2001","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1111\/j.1529-8019.2011.01430.x-BIB189|cit94","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00520-009-0744-x","article-title":"A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC skin toxicity study group","volume":"18","author":"Lacouture","year":"2010","journal-title":"Support Care Cancer"},{"key":"10.1111\/j.1529-8019.2011.01430.x-BIB95|cit95","unstructured":"National Cancer Institute Cancer therapy evaluation program. common terminology criteria for adverse events (CTCAE) v4.0 http:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1529-8019.2011.01430.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1529-8019.2011.01430.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T17:58:34Z","timestamp":1671818314000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1529-8019.2011.01430.x"}},"subtitle":["Treatment of chemotherapy-induced alopecia"],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":95,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,7]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1529-8019.2011.01430.x","relation":{},"ISSN":["1396-0296"],"issn-type":[{"value":"1396-0296","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}